In a statement, the company said it was “sympathetic with the volunteer’s medical condition” but that there is “absolutely no correlation with the vaccine trial and the medical condition of the volunteer.” The Pune-based drug manufacturer stressed that the volunteer was “specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent,” but the individual “still chose to go public and malign the reputation” of SII. 

The volunteer, a 40-year-old man from Chennai, claims he suffered severe neurological damage after taking part in the phase three trial of Covishield. He sued SII for Rs 5 crore ($676,000 USD) and demanded SII, AstraZeneca and the Oxford Vaccine Group immediately halt vaccine trials, involving some 1,600 volunteers.



Read more…